Emma Collins BSc
Design and synthesis of novel iron chelators as a therapy for thalassaemia patients
Emma attended Kingston University London between the years of 2015-2018 and was awarded a BSc in Genetics and Molecular Biology. As part of her BSc she was given the opportunity to travel to Malta for an Erasmus project placement in the summer of 2017. While in Malta, Emma was allocated to assist with the Genetics Department of the University of Malta. Her work there focussed on assisting and developing a novel national screening programme for patients suffering from thalassaemia and other genetic blood disorders.
After she graduated from Kingston University, Emma applied and was awarded a place at Imperial College London within the School of Medicine on their graduate entry pathway. After some years studying medicine, Emma returned to Kingston University London to undertake a PhD project in novel drug design. Her project specifically revolves around the development of novel iron chelators (a majora aspect of managing thalassaemia). Due to the experience she gained on her Erasmus placement she has gained a significant understanding of the mechanism of haemoglobin dissorders, chelation, and the issues faced by people with such genetic disorder when undergoing chelation therapy.